These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38143504)

  • 1. Efficacies of S-nitrosoglutathione (GSNO) and GSNO reductase inhibitor in SARS-CoV-2 spike protein induced acute lung disease in mice.
    Kim J; Qiao F; Singh AK; Won J; Singh I
    Front Pharmacol; 2023; 14():1304697. PubMed ID: 38143504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis.
    Saxena N; Won J; Choi S; Singh AK; Singh I
    Free Radic Biol Med; 2018 Jun; 121():57-68. PubMed ID: 29694854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.
    Blonder JP; Mutka SC; Sun X; Qiu J; Green LH; Mehra NK; Boyanapalli R; Suniga M; Look K; Delany C; Richards JP; Looker D; Scoggin C; Rosenthal GJ
    BMC Pulm Med; 2014 Jan; 14():3. PubMed ID: 24405692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-Aminobenzoyl-S-nitrosoglutathione: A fluorogenic, cell permeable, pseudo-substrate for S-nitrosoglutathione reductase.
    Sun BL; Palmer L; Alam SR; Adekoya I; Brown-Steinke K; Periasamy A; Mutus B
    Free Radic Biol Med; 2017 Jul; 108():445-451. PubMed ID: 28419866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases.
    Sun X; Wasley JW; Qiu J; Blonder JP; Stout AM; Green LS; Strong SA; Colagiovanni DB; Richards JP; Mutka SC; Chun L; Rosenthal GJ
    ACS Med Chem Lett; 2011 May; 2(5):402-6. PubMed ID: 24900320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of B cell functions by S-nitrosoglutathione in the EAE model.
    Kim J; Islam SMT; Qiao F; Singh AK; Khan M; Won J; Singh I
    Redox Biol; 2021 Sep; 45():102053. PubMed ID: 34175668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.
    Bodas M; Silverberg D; Walworth K; Brucia K; Vij N
    Antioxid Redox Signal; 2017 Sep; 27(7):433-451. PubMed ID: 28006950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an Allosteric
    Fontana K; Onukwue N; Sun BL; Lento C; Ventimiglia L; Nikoo S; Gauld JW; Wilson DJ; Mutus B
    Antioxidants (Basel); 2019 Nov; 8(11):. PubMed ID: 31766125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase.
    Green LS; Chun LE; Patton AK; Sun X; Rosenthal GJ; Richards JP
    Biochemistry; 2012 Mar; 51(10):2157-68. PubMed ID: 22335564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracheomalacia in bronchopulmonary dysplasia: Trachealis hyper-relaxant responses to S-nitrosoglutathione in a hyperoxic murine model.
    Einisman HJ; Gaston B; Wijers C; Smith LA; Lewis TH; Lewis SJ; Raffay TM
    Pediatr Pulmonol; 2019 Dec; 54(12):1989-1996. PubMed ID: 31486289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Nitrosoglutathione Mimics the Beneficial Activity of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide in a Mouse Model of Stroke.
    Khan M; Dhammu TS; Qiao F; Kumar P; Singh AK; Singh I
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104470. PubMed ID: 31680031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-nitrosoglutathione supplementation to ovalbumin-sensitized and -challenged mice ameliorates methacholine-induced bronchoconstriction.
    Foster MW; Yang Z; Potts EN; Michael Foster W; Que LG
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L739-44. PubMed ID: 21784966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting GSNOR for functional recovery in a middle-aged mouse model of stroke.
    Khan M; Kumar P; Qiao F; Islam SMT; Singh AK; Won JS; Feng W; Singh I
    Brain Res; 2020 Aug; 1741():146879. PubMed ID: 32418890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma.
    Colagiovanni DB; Drolet DW; Langlois-Forget E; Piché MP; Looker D; Rosenthal GJ
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):115-24. PubMed ID: 22210450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
    Bhargavan B; Kanmogne GD
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilatory responses during and following exposure to a hypoxic challenge in conscious mice deficient or null in S-nitrosoglutathione reductase.
    Palmer LA; May WJ; deRonde K; Brown-Steinke K; Bates JN; Gaston B; Lewis SJ
    Respir Physiol Neurobiol; 2013 Feb; 185(3):571-81. PubMed ID: 23183419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.
    Barnett SD; Buxton ILO
    Crit Rev Biochem Mol Biol; 2017 Jun; 52(3):340-354. PubMed ID: 28393572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy.
    Paidi RK; Jana M; Mishra RK; Dutta D; Raha S; Pahan K
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):59-70. PubMed ID: 33426604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous Nitric Oxide Enhances Disease Resistance by Nitrosylation and Inhibition of
    Yu Z; Cao J; Zhu S; Zhang L; Peng Y; Shi J
    Front Plant Sci; 2020; 11():543. PubMed ID: 32670301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD.
    Muthukaman N; Deshmukh S; Tondlekar S; Tambe M; Pisal D; Sarode N; Mhatre S; Chakraborti S; Shah D; Bhosale VM; Kulkarni A; Mahat MYA; Jadhav SB; Gudi GS; Khairatkar-Joshi N; Gharat LA
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3766-3773. PubMed ID: 30340896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.